XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.2

Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Financial Information with Respect to Company's Reportable Segments

Presented below is the financial information with respect to the Company’s reportable segments:

		Three Months Ended June 30,
(in thousands)		2019				2018
Revenue:
Therapeutics		$	4,819			$	1,447
Food			570				427
Total segment revenue			5,389				1,874
Segment operational cash expenditures:
Therapeutics		$	14,872			$	4,926
Food			2,077				674
Total segment operational cash expenditures			16,949				5,600
Allocation of centralized research and development operational    cash expenditures:
Therapeutics		$	3,118			$	1,905
Food			—				816
Total allocation of centralized research and development    operational cash expenditures			3,118				2,721
Segment operating loss:
Therapeutics		$	(13,171	)		$	(5,384	)
Food			(1,507	)		$	(1,063	)
Total segment operating loss			(14,678	)			(6,447	)
Adjustments to reconcile segment operating loss to consolidated    loss from operations:
Corporate general and administrative cash expenditures		$	(11,123	)		$	(2,118	)
Interest income received			(1,485	)			(299	)
Depreciation and amortization			(1,168	)			(512	)
Share-based compensation			(2,279	)			(255	)
Loss on disposal of assets			(22	)			(3	)
Changes in prepaids, accounts payable and accrued expenses			6,884				(2,491	)
Total consolidated loss from operations		$	(23,871	)		$	(12,125	)

		Six Months Ended June 30,
(in thousands)		2019				2018
Revenue:
Therapeutics		$	9,638			$	2,894
Food			1,213				508
Total segment revenue			10,851				3,402
Segment operational cash expenditures:
Therapeutics		$	27,782			$	14,176
Food			4,184				1,733
Total segment operational cash expenditures			31,966				15,909
Allocation of centralized research and development operational    cash expenditures:
Therapeutics		$	6,871			$	3,942
Food			—				1,233
Total allocation of centralized research and development    operational cash expenditures			6,871				5,175
Segment operating loss:
Therapeutics		$	(25,015	)		$	(15,224	)
Food			(2,971	)			(2,458	)
Total segment operating loss			(27,986	)			(17,682	)
Adjustments to reconcile segment operating loss to consolidated    loss from operations:
Corporate general and administrative cash expenditures		$	(18,145	)		$	(4,677	)
Interest income received			(2,086	)			(522	)
Depreciation and amortization			(2,107	)			(970	)
Share-based compensation			(3,828	)			(405	)
Loss on disposal of assets			(22	)			(10	)
Changes in prepaids, accounts payable and accrued expenses			10,809				2,906
Total consolidated loss from operations		$	(43,365	)		$	(21,360	)

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration